|
PSMA5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93953999999552E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.21079999999096E-05 |
| Normal-vs-Stage2 |
3.218100E-02 |
| Normal-vs-Stage3 |
3.98420000000677E-05 |
| Normal-vs-Stage4 |
3.000600E-03 |
| Stage1-vs-Stage2 |
9.378100E-02 |
| Stage1-vs-Stage3 |
8.622400E-01 |
| Stage1-vs-Stage4 |
6.304200E-01 |
| Stage2-vs-Stage3 |
8.152200E-02 |
| Stage2-vs-Stage4 |
3.259800E-01 |
| Stage3-vs-Stage4 |
5.681800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.57203999999744E-05 |
| Normal-vs-AfricanAmerican |
3.782500E-02 |
| Normal-vs-Asian |
2.120800E-03 |
| Caucasian-vs-AfricanAmerican |
3.357200E-01 |
| Caucasian-vs-Asian |
5.232000E-01 |
| AfricanAmerican-vs-Asian |
6.409400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.576800E-04 |
| Normal-vs-Female |
4.5517000000217E-06 |
| Male-vs-Female |
7.156800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.03379999996756E-06 |
| Normal-vs-Age(41-60Yrs) |
2.030100E-04 |
| Normal-vs-Age(61-80Yrs) |
4.375500E-03 |
| Normal-vs-Age(81-100Yrs) |
5.915800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.600560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.209180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.781200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.608400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.155800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.961600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.037800E-04 |
| Classical-VS-Follicular |
1.638870E-04 |
| Classical-VS-Other |
5.464800E-01 |
| Classical-VS-Normal |
5.46170000004231E-07 |
| Tall-VS-Follicular |
2.68419997340175E-09 |
| Tall-VS-Other |
9.274200E-02 |
| Tall-VS-Normal |
6.04300054440898E-10 |
| Follicular-VS-Other |
4.575600E-01 |
| Follicular-VS-Normal |
4.192200E-01 |
| Other-VS-Normal |
1.878990E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.041510E-03 |
| Normal-vs-N1 |
2.282300E-02 |
| N0-vs-N1 |
6.292800E-01 |
|
|
